Full Text View
Tabular View
No Study Results Posted
Related Studies
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
This study is currently recruiting participants.
Study NCT00346385   Information provided by ImmunoGen, Inc.
First Received: June 28, 2006   Last Updated: August 3, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Cancer
Ovarian Cancer
Merkel Cell Carcinoma
Lung Cancer
Sarcoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Merkel Cell
Lung Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adnexal Diseases
Carcinoma, Neuroendocrine
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Ovarian Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Urogenital Neoplasms
Interventions listed in this trial
BB-10901
Sponsors listed in this trial
ImmunoGen, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services